We initially also included Msh6-/- mice, but they did not tolerate ENU treatment (Fig 2) even at a reduced dose (Table 1), as they developed thymic tumors with enlarged lymph nodes and spleens (data not shown). This evidence concerns the gene MSH6 and thymus neoplasm.